(Q46424835)

22 December 2017

title

In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

1 reference

Danielle Swinne

1

1 reference

22 December 2017

Mirjam Watelle

series ordinal

2

1 reference

22 December 2017

Nicole Nolard

series ordinal

3

1 reference

22 December 2017

publication date

1 March 2005

1 reference

22 December 2017

Revista iberoamericana de micologia

published in

1 reference

22 December 2017

volume

22

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

24-28

1 reference

22 December 2017

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

Quality control limits for broth microdilution susceptibility tests of ten antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2805%2970002-4

7 January 2021

10.1016/S1130-1406(05)70002-4

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017